Infliximab: an alternative treatment for refractory immune thrombocytopenic purpura related to Crohn's disease?

Inflamm Bowel Dis. 2007 Nov;13(11):1452-3. doi: 10.1002/ibd.20209.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / complications*
  • Humans
  • Infliximab
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / etiology
  • Salvage Therapy

Substances

  • Antibodies, Monoclonal
  • Infliximab